Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francisnaira da Silva Santos has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structure–Activity Relationship Analysis of Flavonoids Isolated from the Leaves of Erythroxylum rimosum O. E. Schulz

    by Ivana P. dos Santos, Maria Eduarda V. Costa, Geovana A. de Oliveira, Francisnaira S. Santos, Débora O. S. Vitória, Robson Almeida Silva, Janaina M. C. Do Vale, Gildeon S. Marques, Ademir Evangelista Do Vale, Milena Botelho Pereira Soares, et al.

    The flavonoids constitute a class of secondary metabolites distributed in plants, occurring in free form (aglycone) or conjugated sugars (glycosides), and are notable for their recognized pharmacological potential. This study investigated flavonoids isolated from the leaves of Erythroxylum rimosum, correlating their chemical structures with biological activities evaluated in vitro assays. The flavonoids did not show significant cytotoxicity in mammalian cells (CC50 > 100 μM), while flavonoids 4 and 5, glycosylated with six-carbon sugar, inhibited the promastigote forms of L. braziliensis with IC50 of 10.34 ± 0.70 μM and 10.14 ± 0.50 μM, respectively. In intracellular infection models, they reduced ~43% of parasitized cells and ~40% of amastigotes. Scanning electron microscopy demonstrated changes in promastigotes, including loss of membrane integrity and flagellum shortening. A molecular docking study with L. mexicana arginase suggested enzyme inhibition as a possible mechanism of action, influenced by sugar chirality. In the antioxidant evaluation, using the DPPH and β-carotene methods, quercetin showed the best inhibitory concentration value (IC50 = 0.22 ± 0.94 mg/mL), followed by glycoside 5 (IC50 = 0.42 ± 0.09 mg/mL). In addition, the flavonoids glycosylated with five-carbon sugar inhibited the acetylcholinesterase enzyme.

  • FERAI, a novel brominated chalcone, induces ultrastructural alterations and apoptosis like-death in Leishmania braziliensis

    by Francisnaira da Silva Santos, Gleice Rayanne Silva, Laísia Alonso Uzêda, Catarina Araújo Menezes Campos, Fernando Leite Ferreira, Felipe Sarmento Guerra, Luís Cesar Rodrigues, Hemerson Iury Ferreira Magalhães, Francisco Jaime Bezerra Mendonça Junior, Milena Botelho Pereira Soares, et al.


  • Computer-Aided Drug Design Studies in Association with in vitro Antileishmanial Tests for New Chalcones

    by Gleice R. da Silva, Francisnaira S. Santos, Fernando F. Leite, Chonny A. H. Acevedo, Natália F. de Sousa, Gabriela B. Grimaldi, Milena B. P. Soares, Elisalva T. Guimarães, Marcus T. Scotti, Luis Cezar Rodrigues, et al.

    In silico and in vitro tests can reveal promising anti-leishmania activity for natural products and their derivatives. The aim of this study was to investigate in silico the pharmacological activities of potential new chalcones and their leishmanicidal potential in vitro. The in silico study was carried out using the PASS, MolPredictX and Molegro Virtual Docker 6.0 programs. Antiparasitic activity was assessed in axenic promastigote and amastigote forms of Leishmania braziliensis. The cytotoxicity tests used the J77G8 cell line. The chalcones exhibited 50% cytotoxic concentration values (CC50) values > 50 μM. Chalcone 4 (named FERAI) presented the best activity with concentration for 50% of promastigotes and intracellular parasites forms (EC50) of 9.75 ± 1.7 and 10.13 ± 1.7 μM for promastigote and amastigote, respectively. Reactive oxygen species (ROS) testing presented increased ROS levels in the parasite at the FERAI concentrations of 10 μM (56.33%), 20 μM (61.76%) and 30 μM (67.13%). Molecular docking revealed interactions (binding energy) between FERAI and the enzymes UDP-glycosyl pyrophosphorylase (-56.8384), dihydroorotate-dehydrogenase (-132.276) and trypanothione-reductase (-151.281). Our results demonstrated the anti-leishmanial activity of chalcones, especially FERAI, with a noted raising of ROS levels in the parasite. Molecular docking revealed dihydroorotate dehydrogenase and trypanothione reductase as potential pharmacological targets for FERAI.